3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Unknown
2
Recruiting
2
Withdrawn
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Conditions
Ovarian Neoplasms
406
Uterine Cervical Neoplasms
400
Endometrial Neoplasms
197
Carcinoma, Ovarian Epithelial
100
Breast Neoplasms
72
Fallopian Tube Neoplasms
71
Uterine Cervical Dysplasia
68
Neoplasms
51
Colorectal Neoplasms
42
Pancreatic Neoplasms
40
Stomach Neoplasms
39
Peritoneal Neoplasms
32
Papillomavirus Infections
32
Recurrence
31
Uterine Neoplasms
29
Vulvar Neoplasms
27
Prostatic Neoplasms
26
Lung Neoplasms
24
Esophageal Neoplasms
23
Urinary Bladder Neoplasms
22
Melanoma
20
Colonic Neoplasms
20
Head and Neck Neoplasms
19
Gynecologic Cancer
19
Endometrial Hyperplasia
18
Neoplasm Metastasis
17
Carcinoma, Non-Small-Cell Lung
17
Squamous Intraepithelial Lesions
16
Sarcoma
16
Ovarian Cysts
15
Interventions
niraparib
1
anlotinib
1
PHI-101
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Platinum-resistant Ovarian Cancer
×
Gynecologic
×
Clear all
NCT04678102
2023-06-26
CREATIVE
Seoul National University Hospital
Phase 1
Unknown
36 enrolled
NCT04376073
2020-11-25
ANNIE
Sun Yat-sen University
Phase 2
Unknown
40 enrolled